Change in HbA1c (glycosylated haemoglobin) Week 0, week 30 [clinicaltrials_resource:00044e7c97791a55d3b3f82418c30ba6]
Injected subcutaneously (s.c. under the skin) once-weekly. As add-on to the pre-trial background medication.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Change in HbA1c (glycosylated haemoglobin) Week 0, week 30 [clinicaltrials_resource:00044e7c97791a55d3b3f82418c30ba6]
Injected subcutaneously (s.c. under the skin) once-weekly. As add-on to the pre-trial background medication.
Bio2RDF identifier
00044e7c97791a55d3b3f82418c30ba6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:00044e7c97791a55d3b3f82418c30ba6
measure [clinicaltrials_vocabulary:measure]
Change in HbA1c (glycosylated haemoglobin)
time frame [clinicaltrials_vocabulary:time-frame]
Week 0, week 30
description
Injected subcutaneously (s.c. ...... e-trial background medication.
identifier
clinicaltrials_resource:00044e7c97791a55d3b3f82418c30ba6
title
Change in HbA1c (glycosylated haemoglobin) Week 0, week 30
@en
type
label
Change in HbA1c (glycosylated ...... 44e7c97791a55d3b3f82418c30ba6]
@en